Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Suven Life Sciences rises on securing product patents in Mexico, New Zealand

07-Aug2018

Suven Life Sciences rises on securing product patents in Mexico, New Zealand

Suven Life Sciences is currently trading at Rs. 226.40, up by 1.30 points or 0.58% from its previous closing of Rs. 225.10 on the BSE.

The scrip opened at Rs. 225.00 and has touched a high and low of Rs. 228.85 and Rs. 224.40 respectively. So far 26023 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 250.80 on 29-Jan-2018 and a 52 week low of Rs. 155.00 on 11-Aug-2017.

Last one week high and low of the scrip stood at Rs. 234.00 and Rs. 220.00 respectively. The current market cap of the company is Rs. 2881.68 crore.

The promoters holding in the company stood at 60.00%, while Institutions and Non-Institutions held 6.69% and 33.31% respectively.

Suven Life Sciences has secured one product patent from Mexico and one product patent from New Zealand corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and patents are valid through 2030 and 2036 respectively.

The granted claims of the patents include the class of selective H3 and 5-HT4 compounds respectively and are being developed as therapeutic agents for neurodegenerative disorders such as for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Parkinson and Schizophrenia and sleep disorders like Narcolepsy etc.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.


Related News

View all news

SpiceJet flies high on the bourses

Spicejet is currently trading at Rs. 77.25, up by 0.65 points or 0.85% from its previous closing of Rs. 76.60 on the BSE.The scrip opened at Rs. 76.90 and has touched a high and low of Rs. 78.00 and Rs.......

Linde India gains on reporting 62% rise in Q4 net profit

Linde India is currently trading at Rs. 436.00, up by 3.05 points or 0.70% from its previous closing of Rs. 432.95 on the BSE.The scrip opened at Rs. 440.00 and has touched a high and low of Rs. 443.75......

Tata Motors surges on the bourses

Tata Motors is currently trading at Rs. 165.30, up by 1.80 points or 1.10% from its previous closing of Rs. 163.50 on the BSE.The scrip opened at Rs. 165.00 and has touched a high and low of Rs. 166.50......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......